Trade Ideas Finds Your Next Trade in Editas Medicine, Inc.

THURSDAY

EDIT

Editas Medicine, Inc.

SCoRE: 58

LAST PRICE - AT THE CLOSE

EDIT is UP 102% since the begininning of the year

EDIT is UP 4% ABOVE 20 day SMA

EDIT is UP 9% ABOVE 200 day SMA

PROFITABLE: NO
EPS: $-0.28

EARNINGS MOMENTUM: NO
0.2% DECREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00

REVENUE IS: 46M

DEBT IS: 79K

CASH IS: 166M

	THE STOCK IS 97.4% AWAY FROM ALL-TIME HIGHS OF $99.95
	EDIT IS UP 102% SINCE THE BEGINNING OF THE YEAR
	EDIT IS UP 29% OVER THE PAST 12 MONTHS
	EDIT IS DOWN -4% OVER THE PAST 1 MONTH
	9% OF ALL EDIT INVESTORS ARE BETTING AGAINST EDIT
	NUM INVESTORS SHORT EDIT HAS GONE UP N/A% VERSUS LAST MONTH